Skip to main content
Insights into Imaging

Table 3 Effect of therapy on body composition parameters and intestinal improvement

From: Magnetic resonance imaging-based body composition is associated with nutritional and inflammatory status: a longitudinal study in patients with Crohn's disease

 

Biological agents (n = 38)

Non-biological agents (n = 11)

P1

P2

P3

ΔSMI, cm2/m2

4.38 ± 4.61

1.62 ± 4.46

< 0.001

0.26

0.0499

ΔSAI, cm2/m2

4.51 ± 8.07

4.68 ± 17.13

< 0.001

0.39

0.93

ΔVAI, cm2/m2

3.75 ± 10.47

0.37 ± 11.22

0.017

0.92

0.61

ΔVA/TA index, %

− 3.22 ± 7.23

− 4.51 ± 4.63

0.009

0.009

0.58

Intestinal improvement, n

24

6

–

–

0.73

  1. p values below 0.05 are marked in bold
  2. SMI Skeletal muscle index, SAI subcutaneous adipose tissue index, VAI visceral adipose tissue index, VA/TA area of visceral fat/area of subcutaneous fat; P1 intra-group differences between baseline and follow-up values in patients group with biologic therapy type; P2 intra-group differences between baseline and follow-up values in patients group with non-biologic therapy type; P3 inter-group differences evaluated using the independent samples t-test or Mann–Whitney U test, and the χ2 test
Back to article page